These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 39008499)

  • 1. Effect of progestin-based contraceptives on HIV-associated vaginal immune biomarkers and microbiome in adolescent girls.
    Nasr MA; Aldous A; Daniels J; Joy C; Capozzi E; Yang M; Moriarty P; Emmanuel-Baker V; Malcolm S; Green SJ; Gomez-Lobo V; Ghosh M
    PLoS One; 2024; 19(7):e0306237. PubMed ID: 39008499
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of Hormonal Contraceptive Use and HIV on Cervicovaginal Cytokines and Microbiota in Malawi.
    Haddad LB; Tang JH; Davis NL; Kourtis AP; Chinula L; Msika A; Tegha G; Hosseinipour MC; Nelson JAE; Hobbs MM; Gajer P; Ravel J; De Paris K
    mSphere; 2023 Feb; 8(1):e0058522. PubMed ID: 36622252
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progestin-based contraception regimens modulate expression of putative HIV risk factors in the vaginal epithelium of pig-tailed Macaques.
    Bosinger SE; Tharp GK; Patel NB; Zhao C; Payne TL; Dietz Ostergaard S; Butler K; Ellis S; Johnson RL; Kersh EN; McNicholl JM; Vishwanathan SA
    Am J Reprod Immunol; 2018 Oct; 80(4):e13029. PubMed ID: 30076667
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of combined oral contraceptives, depot medroxyprogesterone acetate and the levonorgestrel-releasing intrauterine system on the vaginal microbiome.
    Brooks JP; Edwards DJ; Blithe DL; Fettweis JM; Serrano MG; Sheth NU; Strauss JF; Buck GA; Jefferson KK
    Contraception; 2017 Apr; 95(4):405-413. PubMed ID: 27913230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Weight change at 12 months in users of three progestin-only contraceptive methods.
    Vickery Z; Madden T; Zhao Q; Secura GM; Allsworth JE; Peipert JF
    Contraception; 2013 Oct; 88(4):503-8. PubMed ID: 23582238
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HIV incidence among women using intramuscular depot medroxyprogesterone acetate, a copper intrauterine device, or a levonorgestrel implant for contraception: a randomised, multicentre, open-label trial.
    Evidence for Contraceptive Options and HIV Outcomes (ECHO) Trial Consortium
    Lancet; 2019 Jul; 394(10195):303-313. PubMed ID: 31204114
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Contribution of Cervicovaginal Infections to the Immunomodulatory Effects of Hormonal Contraception.
    Fichorova RN; Chen PL; Morrison CS; Doncel GF; Mendonca K; Kwok C; Chipato T; Salata R; Mauck C
    mBio; 2015 Sep; 6(5):e00221-15. PubMed ID: 26330510
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Choice of the levonorgestrel intrauterine device, etonogestrel implant or depot medroxyprogesterone acetate for contraception after aspiration abortion.
    Steinauer JE; Upadhyay UD; Sokoloff A; Harper CC; Diedrich JT; Drey EA
    Contraception; 2015 Dec; 92(6):553-9. PubMed ID: 26093190
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential effects of depot medroxyprogesterone acetate administration on vaginal microbiome in Hispanic White and Black women.
    Yang L; Hao Y; Hu J; Kelly D; Li H; Brown S; Tasker C; Roche NE; Chang TL; Pei Z
    Emerg Microbes Infect; 2019; 8(1):197-210. PubMed ID: 30866773
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of the depot medroxyprogesterone acetate injectable and levonorgestrel implant on HIV genital shedding: a randomized trial.
    Chinula L; Nelson JAE; Wiener J; Tang JH; Hurst S; Tegha G; Msika A; Ellington S; Hosseinipour MC; Mataya R; Haddad LB; Kourtis AP
    Contraception; 2018 Sep; 98(3):193-198. PubMed ID: 29746813
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Zim CHIC: A cohort study of immune changes in the female genital tract associated with initiation and use of contraceptives.
    Achilles SL; Meyn LA; Mhlanga FG; Matubu AT; Stoner KA; Beamer MA; Chirenje ZM; Hillier SL
    Am J Reprod Immunol; 2020 Sep; 84(3):e13287. PubMed ID: 32533883
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune biomarkers and anti-HIV activity in the reproductive tract of sexually active and sexually inactive adolescent girls.
    Ghosh M; Jais M; Biswas R; Jarin J; Daniels J; Joy C; Juzumaite M; Emmanuel V; Gomez-Lobo V
    Am J Reprod Immunol; 2018 Jun; 79(6):e12846. PubMed ID: 29533494
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cervical and systemic concentrations of long acting hormonal contraceptive (LARC) progestins depend on delivery method: Implications for the study of HIV transmission.
    Buckner LR; Drobnis EZ; Augustine MS; Rogers LK; Akers J; Mott PD; Hope TJ; Quayle AJ; Schust DJ
    PLoS One; 2019; 14(5):e0214152. PubMed ID: 31095572
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of progestins on immunity: medroxyprogesterone but not norethisterone or levonorgestrel suppresses the function of T cells and pDCs.
    Huijbregts RP; Michel KG; Hel Z
    Contraception; 2014 Aug; 90(2):123-9. PubMed ID: 24674041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of Depot Medroxyprogesterone Acetate, Copper Intrauterine Devices, and Levonorgestrel Implants on Early HIV Disease Progression.
    Morrison CS; Hofmeyr GJ; Thomas KK; Rees H; Philip N; Palanee-Phillips T; Nanda K; Nair G; Onono M; Mastro TD; Lind M; Heffron R; Edward V; Deese J; Beksinska M; Beesham I; Stringer JSA; Baeten JM; Ahmed K;
    AIDS Res Hum Retroviruses; 2020 Aug; 36(8):632-640. PubMed ID: 32394723
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Longitudinal Assessment of Cervical Inflammation and Immunity Associated with HIV-1 Infection, Hormonal Contraception, and Pregnancy.
    Morrison CS; Fichorova R; Chen PL; Kwok C; Deese J; Yamamoto H; Anderson S; Chipato T; Salata R; Doncel GF
    AIDS Res Hum Retroviruses; 2018 Oct; 34(10):889-899. PubMed ID: 30047279
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Behavioral effects of different contraceptive methods and HIV acquisition: an ancillary study of the ECHO randomized trial.
    Singata-Madliki M; Lawrie TA; Balakrishna Y; d'Hellencourt FC; Hofmeyr GJ
    Reprod Health; 2021 Sep; 18(1):192. PubMed ID: 34587971
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medroxyprogesterone acetate and levonorgestrel increase genital mucosal permeability and enhance susceptibility to genital herpes simplex virus type 2 infection.
    Quispe Calla NE; Vicetti Miguel RD; Boyaka PN; Hall-Stoodley L; Kaur B; Trout W; Pavelko SD; Cherpes TL
    Mucosal Immunol; 2016 Nov; 9(6):1571-1583. PubMed ID: 27007679
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genital Injury Signatures and Microbiome Alterations Associated With Depot Medroxyprogesterone Acetate Usage and Intravaginal Drying Practices.
    Birse KD; Romas LM; Guthrie BL; Nilsson P; Bosire R; Kiarie J; Farquhar C; Broliden K; Burgener AD
    J Infect Dis; 2017 Feb; 215(4):590-598. PubMed ID: 28011908
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of depot medroxyprogesterone acetate, the copper IUD and the levonorgestrel implant on testosterone, sex hormone binding globulin and free testosterone levels: ancillary study of the ECHO randomized clinical trial.
    Hofmeyr GJ; Singata-Madliki M; Batting J; Balakrishna Y; Morroni C
    BMC Womens Health; 2024 Mar; 24(1):167. PubMed ID: 38459552
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.